Nader Francois 4

What Happened

• Nader Francois, a director of Tectonic Therapeutic, reported an award/acquisition of 20,400 derivative shares on 2026-04-01. The reported acquisition price was $0.00 (no cash exchanged), and the transaction is recorded as an award/grant (Form 4 code A).

Key Details

• Transaction date: April 1, 2026; Form 4 filed April 3, 2026 (Accession 0001365343-26-000003).
• Award: 20,400 shares acquired at $0.00 (derivative/security award).
• Vesting (per footnote): One-third vests on April 1, 2027; the balance vests in 24 equal monthly installments thereafter, subject to continuous service through each vesting date.
• Shares owned following the transaction: not specified in the provided report.
• No 10b5-1 plan, tax-withholding, or immediate sale noted in the filing.
• Filing appears timely (filed within two business days of the reported transaction date).

Context

• This is a compensation-style award (derivative grant) that vests over time rather than an open-market purchase or sale. Such grants compensate and retain insiders; they do not reflect an immediate cash investment or divestiture. Because vesting is service-based, the shares will become transferable only as they vest.